Advertisement
Screener

Decoy Therapeutics Inc. (DCOY) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

Decoy Therapeutics Inc. Shares Authorized

Decoy Therapeutics Inc. (DCOY) had Shares Authorized of 100.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-12

  • 2026-06-30: Common Stock, Shares Authorized 100.00M shares.
  • 2026-03-31: Common Stock, Shares Authorized 100.00M shares.
  • 2025-12-31: Common Stock, Shares Authorized 100.00M shares.
  • 2025-09-30: Common Stock, Shares Authorized 100.00M shares.
Period endCommon Stock, Shares Authorized
2026-06-30100.00M shares
10-Q · filed 2026-08-12
2026-03-31100.00M shares
10-Q · filed 2026-05-08
2025-12-31100.00M shares
10-Q · filed 2026-08-12
2025-09-30100.00M shares
10-Q · filed 2025-11-14
2025-06-30100.00M shares
10-Q · filed 2025-08-12
2025-03-31100.00M shares
10-Q · filed 2025-05-14
2024-12-31100.00M shares
10-Q · filed 2025-11-14
2024-09-30100.00M shares
10-Q · filed 2024-11-14
2024-06-30100.00M shares
10-Q · filed 2024-08-09
2024-03-31100.00M shares
10-Q · filed 2024-05-13
2023-12-31100.00M shares
10-K · filed 2025-03-21
2023-09-30100.00M shares
10-Q · filed 2023-11-09
2023-06-30100.00M shares
10-Q · filed 2023-08-10
2023-03-31100.00M shares
10-Q · filed 2023-05-11
2022-12-31100.00M shares
10-K · filed 2024-03-22
2022-09-30100.00M shares
10-Q · filed 2022-11-10
2022-06-30100.00M shares
10-Q · filed 2022-08-05
2022-03-31100.00M shares
10-Q · filed 2022-05-12
2021-12-31100.00M shares
10-K · filed 2023-03-27
2021-09-30100.00M shares
10-Q · filed 2021-11-04
2021-06-30100.00M shares
10-Q · filed 2021-08-05
2021-03-31100.00M shares
10-Q · filed 2021-05-12
2020-12-31100.00M shares
10-K · filed 2022-03-25
2020-09-30100.00M shares
10-Q · filed 2020-11-12
2020-06-30100.00M shares
10-Q · filed 2020-08-12
2020-03-31100.00M shares
10-Q/A · filed 2020-05-15
2019-12-31100.00M shares
10-K · filed 2021-03-18
2019-09-30100.00M shares
10-Q · filed 2019-11-12
2019-06-30100.00M shares
10-Q · filed 2019-07-17
2019-03-31100.00M shares
10-Q · filed 2019-05-01
2018-12-31100.00M shares
10-K · filed 2020-03-23
2018-09-30100.00M shares
10-Q · filed 2018-11-05
2018-06-30100.00M shares
10-Q · filed 2018-08-01
2018-03-31100.00M shares
10-Q · filed 2018-05-02
2017-12-31100.00M shares
10-K · filed 2019-03-06
2017-09-30100.00M shares
10-Q · filed 2017-11-06
2017-06-30100.00M shares
10-Q · filed 2017-08-02
2017-03-31100.00M shares
10-Q · filed 2017-05-03
2016-12-31100.00M shares
10-K · filed 2018-03-07
2016-09-30100.00M shares
10-Q · filed 2016-11-02
2016-06-30100.00M shares
10-Q · filed 2016-08-03
2016-03-31100.00M shares
10-Q · filed 2016-05-04
2015-12-31100.00M shares
10-K · filed 2017-03-08
2015-09-30100.00M shares
10-Q · filed 2015-11-04
2015-06-30100.00M shares
10-Q · filed 2015-08-05
2015-03-31100.00M shares
10-Q · filed 2015-05-06
2014-12-3161.00M shares
10-K · filed 2016-03-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Protagenic Therapeutics, Inc.\new (PTIX)United States$0.001B
Silo Pharma, Inc. (SILO)United States$0.003B-1.57